Home > Rheumatology > ACR 2021 > COVID-19: What You Need to Know > Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By
Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA
Conference
ACR 2021
Compared with the general population, breakthrough infections after COVID-19 vaccination happen more often in patients who suffer from autoimmune or inflammatory rheumatic diseases. The risk of infection is affected by the type of medication and pre-existing diagnosis. “COVID-19 vaccines are highly effective in the general population, but we also know that in certain populations, such as elderly and severely immunocompromised, they may have reduced effectiveness,” Prof. Jasvinder Singh (University of Alabama at Birmingham, AL, USA) explained [1]. For certain drug classes, like glucocorticoids and B-cell depleting agents, a reduction in antibody response has already been found, but much is unknown about other treatments and rheumatic diseases [2]. Therefore, the current study aimed to investigate the possibility of an increased risk for breakthrough infection after COVID-19 vaccination in patients with autoimmune or inflammatory rheumatic diseases [1]. Data...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on